With obvious caveats due to the model systems used, these results imply that the 22 AD risk modifier genes are unlikely to directly modulate tau uptake, seeding, or aggregate maintenance in a cell‐autonomous fashion. The gene discussed is MAPT; the disease is Alzheimer disease.